IMNM vs SBAC · $2.47B cap vs P/E 30, rev $719.6M
Immunome Inc (IMNM) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported SBAC revenue for 2025-12-31 was $719.6M. Net income was $370.3M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
IMNM currently screens at market cap $2.47B. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the IMNM and SBAC stock pages for the full models.
Not investment advice.